Thus, unlike autoimmune diseases such as RA, IL-6 and TNF-α may not be ideal therapeutic targets of ALS and the elevation of these two cytokines may be due to a secondary event of neuroinflammation rather than a cause of disease. This evidence concerns the gene IL6 and autoimmune disease.